By NewsDesk @infectiousdiseasenews
The Executive Director of the University of New Hampshire Health & Wellness, Kevin Charles said in an update on mumps Friday the four cases of confirmed mumps and two probable remains limited to individuals who had close contact with one another and the risk to the larger community is low.
School officials are working closely with the state health department to prevent further spread on campus.
Health officials from the New Hampshire Division of Public Health Services are working with UNH to target a third dose of the MMR (measles, mumps and rubella) vaccine to a select group of students within the affected social network based on published CDC guidance. There is no recommendation for broader vaccination at this time.
Mumps is a contagious disease that is caused by a virus. It typically starts with a few days of fever, headache, muscle aches, tiredness, and loss of appetite. Then most people will have swelling of their salivary glands. This is what causes the puffy cheeks and a tender, swollen jaw.
The CDC says the MMR vaccine is safe and effective. A person with two doses of MMR vaccine has about an 88% reduction in risk for mumps; a person with one dose has a 78% reduction in risk for mumps.
In 2019, approximately 3,500 cases were reported in the US.
- Hawaii: COVID-19 positive individual traveled to Maui and Oahu
- WHO underestimates the spread of the coronavirus: Swedish researchers
- Diamond Princess: US government to evacuate Americans
- Africa coronavirus: Egypt records first COVID-19 case
- Malaysia reports two additional COVID-19 cases, brings total to 21
- Hawaii reports 9th rat lungworm case of 2019
- Costa Rica reports an additional Naegleria fowleri infection